Left Ventricular Dysfunction clinical trials at UCSD
1 research study open to eligible people
Showing trials for
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
open to eligible people ages 18-90
The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart procedure compared to the current standard of care.
San Diego, California and other locations
Our lead scientists for Left Ventricular Dysfunction research studies include Ehtisham Mahmud, MD.
Last updated: